LifeStance Health Group, Inc. (LFST) Tops Q2 EPS by 3c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq rise as tech stocks gain ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts LFST Hot Sheet
Join SI Premium – FREE
LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q2 EPS of $0.06, $0.03 better than the analyst estimate of $0.03. Revenue for the quarter came in at $435.35 million versus the consensus estimate of $414.38 million.
FY 2026 Guidance:-
Revenue between $1.685 billion to $1.725 billion vs consensus $1.66 billion.
For earnings history and earnings-related data on LifeStance Health Group, Inc. (LFST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Arch Capital (ACGL) PT Raised to $106 at Keefe, Bruyette & Woods
- Iren stock climbs as investors buy ahead of earnings
- FDA clears Cepheid test that detects four hemorrhagic fever viruses
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
